Federal Reserve Chair Jerome Powell’s upcoming testimony before Congress is shaping up to be a pivotal moment for monetary policy—and a revealing window into the growing political pressures influencing the Fed’s traditionally insulated decision-making process. As Powell heads to Capitol Hill this week, investors and advisors alike should pay close attention, because what unfolds could…
Vaccine Policy Shake-Up: What Investors Need to Know About the New ACIP and Thimerosal Debate A seismic shift is underway in U.S. vaccine advisory circles, with Health and Human Services Secretary Robert F. Kennedy Jr. appointing a new, controversial Advisory Committee on Immunization Practices (ACIP) lineup. This revamped panel is set to vote on the…
US Inflation and Fed Policy: What Investors Need to Know Now The latest data suggests US inflation inched higher in May, but the increase was modest, offering little evidence so far of the tariff-related price pressures the Federal Reserve has warned could emerge later this year. This nuanced inflation picture is critical for investors and…
As the clock ticks toward 2033, the financial health of Social Security—a cornerstone of retirement security for millions of Americans—remains precarious. The latest Social Security Board of Trustees report confirms what many have feared: the Old-Age and Survivors Insurance Trust Fund may be depleted by 2033, leaving only about 77% of scheduled benefits payable thereafter….